Table 1.
Method | BSPP | SHBS-seq | ACBS-seq | Bisulfite-Patch PCR |
Microdroplet PCR |
|||
---|---|---|---|---|---|---|---|---|
Reference | [47] | [48] | [49] | [51] | [52] | [58] | [60] | [62] |
Capture probes/primer | ssDNA | ssDNA | ssDNA | Biotinylated RNA | Biotinylated RNA | ssDNA | Partial dsDNA | ssDNA |
Probe/primer size | 150 bp | 150 bp | 150 bp | 160 bp | 120 bp | 60 bp | 40–50 bp | 20–30 bp |
Number of probes/primers | 30,000 | 9,552 | 330,000 | 51,551 | n/a | 240,000 | 94 pairs | 3,500 pairs |
Probe/primer manufacturer | Agilent | Agilent | Agilent | Agilent | Agilent | Agilent | Sigma | RainDance |
Capture method | Annealing, extension and circularization | Annealing, extension and circularization | Annealing, extension and circularization | Hybridization in solution | Hybridization in solution | Hybridization on array | Annealing, ligation, and PCR | Microdroplet PCR |
Amount of input DNA | 200 ng bisulfite-treated | 1 µg bisulfite-treated | 200 ng bisulfite-treated | 20–30 µg native | 2–3 µg native | 20 µg bisulfite-treated and amplified | 250 ng bisulfite-treated | 2 µg bisulfite-treated |
Bisulfite treatment | Pre-capture | Pre-capture | Pre-capture | Post-capture | Pre-capture | Pre-capture | Pre-capture | Pre-capture |
Sequencing platform | Illumina | Illumina | Illumina | Illumina | Illumina | Illumina | 454 | Illumina |
Target size | 2.1Mb | n/a | 34Mb | 8.2Mb | 38Mb | 258.9kb | 25.5kb | 1.35Mb |
Number of targets | 10,582 | 9552 | 140,749 | 51,551 | n/a | 324 | 94 | 3,500 |
Target features | CGI, ENCODE, (TSS±1000bp) | ENCODE regions | DMRs, CTCF, DNase I sites | CGI, TSS | Exon | CGI | Promoter | Promoter (TSS±1000bp) |
Targets covered | n/a | 68% (>10 reads) | n/a | 85–88% (>10 reads) | 90% (>10 reads) | ~92% | 100% | 99% |
On-target rate (%) | n/a | n/a | 96% | 77–84% | 71–75% | 6–12% | 90% | 90% |
Number of CpG | 66,000 | 6,400 | 500,0000 | 0.9–1 million | n/a | 25,044 | n/a | 77,674 |
Coverage per CpG | n/a | n/a | n/a | 86–146 (mean) | 58–73 | 95–105 (median) | 444 (median) | >100 (97% of CpGs) |
Reproducibility (r) | 0.97 | 0.965 | 0.97–98 | 0.94 | n/a | n/a | 0.91 | n/a |
Advantages | Highly specific and reproducible, require lower amount of input DNA | Flexible probe design; easy to scale up to target large regions | Use bisulfite-treated and amplified DNA | Require lower amount of DNA, use regular PCR primers | Highly multiplex PCR, low PCR bias | |||
Disadvantages | Expensive probes, complex probe design | Capture small amount of DNA; challenges in bisulfite treatment | Low capture specificity, require specific instruments | Uncertainty about scale-up in throughput | Require specific instruments. |